Skip to search formSkip to main contentSkip to account menu

Plasminogen Activator Inhibitor 2

Known as: Serpin B2, PAI-2, Type 2 Plasminogen Activator Inhibitor 
Member of the serpin family of proteins. It inhibits both the tissue-type and urokinase-type plasminogen activators.
National Institutes of Health

Related topics

Related topics

18 relations
In BloodPlasminogen Activator Inhibitor 1Plasminogen activator inhibitor 2 Ag:ACnc:Pt:PPP:Qn:IAProcess of secretion

Narrower (1)

Plasminogen Activator Inhibitor 2, human

Broader (2)

Plasminogen InactivatorsSerine Proteinase Inhibitors

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2007
2007
Plasminogen activator system in oral squamous cell carcinoma.
Highly Cited
1999
Highly Cited
1999
Expression of plasminogen activator inhibitors 1 and 2 in lung cancer and their role in tumor progression.
The plasminogen activator cascade initiated by urokinase type plasminogen activator (u-PA) is involved in extracellular matrix… 
1999
1999
Localization of plasminogen activators and plasminogen-activator inhibitors in human gingival tissues demonstrated by immunohistochemistry and in situ hybridization.
Highly Cited
1999
Highly Cited
1999
Dissemination risk index based on plasminogen activator system components in primary breast cancer.
PURPOSE To study interactions between disease-free survival (DFS) and four components of the plasminogen activator system… 
1998
1998
Coagulation and Fibrinolytic Parameters in Normal Pregnancy and in Pregnancy Complicated by Intrauterine Growth Retardation
n n 
1996
1996
Inverse Correlation between mRNA Expression of Plasminogen Activator Inhibitor‐2 and Lymph Node Metastasis in Human Breast Cancer
We examined mRNA expressions of urokinase‐type plasminogen activator (u‐PA), its specific receptor (u‐PR), and plasminogen… 
Highly Cited
1994
Highly Cited
1994
Prognostic relevance of plasminogen activators and their inhibitors in colorectal cancer.
Human colorectal carcinogenesis has been shown previously to be associated with impressive changes in the tissue levels of… 
Highly Cited
1993
Highly Cited
1993
Thrombin Stimulates Expression of Tissue-Type Plasminogen Activator and Plasminogen Activator lnhibitor Type 1 in Cultured Human Vascular Smooth Muscle Cells
Summary The effect of thrombin on the fibrinolytic potential of human vascular smooth muscle cells (SMC) in culture was studied… 
Highly Cited
1991
Highly Cited
1991
A synthetic DNA encoding a modified human urokinase resistant to inhibition by serum plasminogen activator inhibitor.
Using DNA synthesis technology we constructed two synthetic DNAs, designated syn-uPA-DNA and mut-uPA-DNA. Syn-uPA-DNA contains… 
Highly Cited
1989
Highly Cited
1989
Characterization of a plasminogen activator and its inhibitor in human mesangial cells.
In the course of some pathological and experimental nephropathies, intraglomerular fibrin deposits develop, possibly as a… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)